Top 10 Gas Utility Stocks To Invest In Right Now

Chris Portale wouldn't mind paying more for his Amazon Prime membership. He uses it to buy heavy items like dog food for his two Weimaraners, Luke and Leia.

NEW YORK (CNNMoney) Amazon said it is thinking about raising the price of Prime membership by as much as $40, hoping it can strike the right balance between managing rising costs and scaring away customers.

Prime members get two-day shipping on a large number of Amazon items at no extra cost, plus the ability to borrow Kindle books and stream movies. Prime currently costs $79 a year, but that might jump to $99 or even $119, according to Amazon (AMZN, Fortune 500) chief financial officer Thomas Szkutak.

An extra $40 would represent a 51% price hike and could push customers away. But the math might still makes sense for Prime members, depending on how often they take advantage of the free two-day shipping option.

Top 10 International Companies To Watch For 2015: Henry Schein Inc. (HSIC)

Henry Schein, Inc. distributes healthcare products and services primarily to office-based healthcare practitioners. It operates in two segments, Healthcare Distribution and Technology. The Healthcare Distribution segment offers consumable dental products, dental laboratory products, and small equipment, including X-ray products, infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, and abrasives; and large dental equipment comprising dental chairs, delivery units and lights, X-ray equipment, equipment repair, and high-tech equipment. It also provides medical products, including branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins; and animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment. The Technology segment offers softwar e and related products, and value-added products that primarily include practice management software systems for dental and medical practitioners, and animal health clinics. Its services also consist of financial services and continuing education services for practitioners. Henry Schein, Inc. primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government and other institutions. It operates in the United States, Australia, Austria, Belgium, Canada, China, the Czech Republic, France, Germany, Hong Kong, Ireland, Israel, Italy, Luxembourg, the Netherlands, New Zealand, Portugal, Slovakia, Spain, Switzerland, and the United Kingdom. The company was founded in 1932 and is headquartered in Melville, New York.

Advisors' Opinion:

• [By John Bonnanzio]

  The fund�� top holdings are Telsa, Henry Schein (HSIC), United Rentals (URI), Gartner (IT) and Kansas City Southern (KSU).

  The fund also has some exposure to pricey biotech. Even so, this is hardly a shoot-the-lights-out growth fund as volatility is below all his mid-cap peers. To that end, this trade actually tempers risk while increasing growth exposure.

• [By Charles Mizrahi]

  Several stocks in our portfolio will benefit from this trend: Drugstore chain Walgreens (WAG), healthcare products distributor Henry Schein (HSIC), and pharmaceutical maker AstraZeneca (AZN)

Top 10 Gas Utility Stocks To Invest In Right Now: Compliance Energy Corp (CEC)

Compliance Energy Corporation (Compliance) is an exploration and development company. The Company is engaged in the acquisition, exploration and development of mineral resource properties. Compliance�� main projects are its freehold coal holdings on Vancouver Island, British Columbia and four non-coal exploration properties on Vancouver Island. Through the Comox Joint Venture (CJV), CEC owns 60% of the Raven Underground Coal project. The Company�� main properties are its approximately 29,000 hectares of freehold coal and mineral interests and 2,046 hectares of Crown Coal licenses in the Comox Coal Basin on Vancouver Island, British Columbia. Through the Comox Joint Venture agreement, Compliance owns 60% of interests and Itochu International and LG International own 20% respectively. Advisors' Opinion:

• [By Lisa Levin]

  CEC Entertainment (NYSE: CEC) surged 1.57% to $44.53. The volume of CEC Entertainment shares traded was 172% higher than normal. CEC Entertainment's trailing-twelve-month ROE is 30.51%.

• [By Geoff Gannon] tal, Oracle (ORCL) etc. may also count ��you are imagining yourself as a shareholder and silent partner in a business that will continue to be controlled by the current management team ��or similar successors ��and in which they will decide what your dividends are each year, they will decide how much stock is issued or bought back, etc.

  Buy and hold investments should be analyzed on a free cash flow basis. Not an EV/EBIT basis. "Value" investments in the Ben Graham sense of the word ��think cigar butts ��should be analyzed on an enterprise value.

  Simply put, make your Ben Graham investments on an EV/EBIT basis. And make your Warren Buffett investments on a price-to-free-cash-flow basis.

  We can think of this as a public owner versus private owner choice. Are you buying the company because you think it is cheap relative to its intrinsic value and you expect to receive your investment gain in the forms of capital gains caused by a rising share price that will close the gap between price and value ��some sort of merger, takeover, etc. ��or do you imagine being invested in the company the way Warren Buffett is invested in Wells Fargo (WFC), Coca-Cola (KO), the Washington Post (WPO), etc.?

  Enterprise value and operating income (��BIT�� should be used when analyzing an investment as a private owner. This is how Joel Greenblatt seems to work. At least that is how he talks in "You Can Be a Stock Market Genius" and how he designed the magic formula (enterprise value and pre-tax ear

Top 10 Gas Utility Stocks To Invest In Right Now: Iamgold Corporation(IAG)

IAMGOLD Corporation, together with its subsidiaries, engages in the exploration, development, and production of mineral resource properties worldwide. It primarily explores for gold, silver, zinc, copper, niobium, diamonds, and other metals. The company holds interests in eight operating gold mines, a niobium producer, a diamond royalty, and exploration and development projects located in Africa and the Americas. Its advanced exploration and development projects include the Westwood project in Canada; and the Quimsacocha project, which consists of 3 mining concessions covering an aggregate area of approximately 8,030 hectares in Ecuador. The company was formerly known as IAMGOLD International African Mining Gold Corporation and changed its name to IAMGOLD Corporation in June 1997. IAMGOLD Corporation was founded in 1990 and is based in Toronto, Canada.

Advisors' Opinion:

• [By Ben Levisohn]

  On an adjusted basis, Eldorado Gold (EGO) has the longest reserve/resource life amongst our coverage companies (39 years) with Goldcorp (GG) having the longest reserve/resource life (23 years) amongst the senior producers versus the group average of 22 years. Kinross Gold (KGC) and Iamgold (IAG) have the shortest adjusted reserve/resource lives amongst the senior and mid-tier producers (18 and 14 years respectively). On a percentage basis, the companies most affected by the adjustment are New Gold (NGD) and Iamgold which both saw reserve/resource lives fall by 47% however, we note that despite the adjustment,�New Gold still has the second longest reserve/resource life in our group (37 years). Newmont Mining was the least affected by the adjustments with reserve/resource life declining by only 12% to 22 years from 25 years.

• [By Holly LaFon]

  He increased his holdings in gold companies in the fourth quarter accordingly. Gold stocks he found attractive in the fourth quarter are: Novagold Resources (NG), Randgold Resources (GOLD), Iamgold Corp. (IAG), Barrick Gold Corp. (ABX), Agnico Eagle (AEM) and International Tower Hill (THM).

• [By Aaron Levitt]

  At just $6.50, AKS is still one of the cheap stocks, but it may not be cheap for long.

  Cheap Stocks to Buy Now: Iamgold (IAG)

  Without a doubt, the most hated metals and mining sector has to be gold mining stocks. Faced with rising costs and falling gold prices, many of the precious metals miners have tanked, moving them into the cheap stocks category.

Top 10 Gas Utility Stocks To Invest In Right Now: Hurco Companies Inc. (HURC)

Hurco Companies, Inc., an industrial technology company, engages in the design, manufacture, and sale of computerized machine tools, computer control systems, and software products to companies in the metal working industry primarily in North America, Europe, and Asia. The company offers general purpose computerized machine tools, such as vertical machining centers/mills and turning centers/lathes. It also provides computer control systems and related software for press brake applications. In addition, the company produces and distributes software options, control upgrades, hardware accessories, and replacement parts for its machine tool product lines, as well as provides operator training and support services to its customers. Hurco Companies, Inc. offers its products to the precision tool, die, and mold manufacturers; independent metal parts manufacturers; and specialized production application or prototype departments within manufacturing operations. It serves aerospace , defense, medical equipment, energy, automotive/transportation, electronics, and computer industries. The company sells its products through independent agents and distributors in North America, Europe, and Asia, a swell as through direct sales personnel in Canada, China, France, Germany, Italy, Poland, Singapore, South Africa, Spain, the United Kingdom, and certain parts of the United States. Hurco Companies, Inc. was founded in 1968 and is headquartered in Indianapolis, Indiana.

Advisors' Opinion:

• [By John Emerson]

  Hardinge (HDNG) the Perfect Fit to the Investment Puzzle
  
  Several years earlier I had started following the machine tool sector and I became quite familiar with Hardinge. Although I never invested in the stock (I had opted for Hurco), I had noted that Jeffrey Gendell had been purchasing shares the company. Hurco (HURC) had much higher margins and it was my belief that the superior quality of their computerized machine tools and their accompanying software were reflected in their earnings. Hurco also held a vastly superior balance sheet at the time I made my investment.

Top 10 Gas Utility Stocks To Invest In Right Now: AMAG Pharmaceuticals Inc.(AMAG)

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (IDA). Its principal product includes Feraheme (ferumoxytol) injection for intravenous (IV) use, which was approved for marketing in the United States in June 2009 by the U.S. Food and Drug Administration, for use as an IV iron replacement therapy for the treatment of IDA in adult patients with chronic kidney disease (CKD). The company is pursuing marketing applications in the European Union, Canada, and Switzerland for Feraheme for the treatment of IDA in CKD patients. AMAG Pharmaceuticals was founded in 1981 and is based in Lexington, Massachusetts.

Advisors' Opinion:

• [By Monica Gerson]

  AMAG Pharmaceuticals (NASDAQ: AMAG) shares fell 16% to $18.38 in the pre-market trading after the company received a CRL from the FDA for the supplemental NDA for Feraheme for broader IDA indication.

• [By John Udovich]

  The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

Top 10 Gas Utility Stocks To Invest In Right Now: Kirrin Resources Inc (KIRRF.PK)

Kirrin Resources Inc. (Kirrin) is a development-stage company. The Company's principal business is the acquisition, exploration and development of uranium and rare earth elements resources properties. Kirrin operates two REE properties, Grevet in Quebec and Bottom Brook in Newfoundland and one uranium project, Alexis River, in southeastern Labrador. It holds its property interests through its wholly owned Alberta subsidiary, Kirrin Exploration Inc. (KEI). It has an option agreement with Altius Resources Inc. to earn a minimum 60%, maximum 100% interest in the Alexis River uranium property, located in southeastern Labrador. It has an option agreement with Ucore Rare Metals Inc. to earn a minimum 50%, maximum 65% interest in the Lost Pond/Bottom Brookrare earth elements and uranium property, located in western Newfoundland. It has an option agreement with Michel Proulx to earn a 100% interest over four years in the Grevet rare earth elements property located in northwestern Quebec. Advisors' Opinion:

• [By The Gold Report]

  Tickers related to the original interview with Don Mosher include: Teck Resources (TCK) and Kirrin Resources (KIRRF.PK).

  DISCLOSURE:
  1) Streetwise Reports does not accept stock in exchange for its services or as sponsorship payment.
  2) Kevin Campbell: I was not paid by Streetwise Reports for participating in this interview. Comments and opinions expressed are my own comments and opinions and may not represent those of Haywood Securities. I had the opportunity to review the interview for accuracy as of the date of the interview and am responsible for the content of the interview.
  3) Interviews are edited for clarity. Streetwise Reports does not make editorial comments or change experts' statements without their consent.
  4) The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer.
  5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned and may make purchases and/or sales of those securities in the open market or otherwise.

Top 10 Gas Utility Stocks To Invest In Right Now: OXiGENE Inc.(OXGN)

OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of vascular disrupting agents (VDAs) that disable and destroy abnormal blood vessels, which provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions. The company?s products include ZYBRESTAT, which is in fosbretabulin in anaplastic cancer of the thyroid (FACT) trial?Phase 2/3 study for the treatment of anaplastic thyroid cancer; in fosbretabulin in advanced lung oncology (FALCON) trial?Phase 2 randomized and controlled study to treat non-small cell lung cancer; in Phase 2 Simon two-stage design study for the treatment of platinum-resistant ovarian cancer; and in Phase 2 randomized controlled study to treat platinum-relapsed but platinum sensitive ovarian cancer. Its products also comprise OXi4503 that is in Phase 1 dose-escalation study for the treatment of acute myelogenous leukemia and myelodysplastic syndromes; Phase 1b dose-ranging study to treat solid tumors with hepatic tumor burden; and Phase 1 dose-escalation study for the treatment of refractory solid tumors. In addition, the company?s products consist of ZYBRESTAT, which is in Phase 2 randomized, double-masked, placebo-controlled, single-dose study for proof-of-mechanism study in polypoidal choroidal vasculopathy. OXiGENE has a strategic collaboration agreement with Symphony Capital Partners, L.P. to support the advancement of ZYBRESTAT for oncology and ophthalmology, and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Bryan Murphy]

  For the second time in as many days, I find myself supporting the purchase of a suddenly-bullish stock by saying "this time is different". Yesterday I was talking about OXiGENE Inc. (NASDAQ:OXGN), but today I'm using the term to describe the bullishness that's unfurling with Neurometrix Inc. (NASDAQ:NURO). And just for the record, yes, I know the perils of the "this time is different" argument. I tend to cringe when I hear it, as (too much) experience has taught me that things are rarely different - patterns within the market play themselves out over and over again. In the case of NURO as well as OXGN though, I can put my finger on something specific that we've not yet seen.

• [By Bryan Murphy]

  In the very short run, OXiGENE Inc. (NASDAQ:OXGN) is overbought and probably due for a setback, not unlike the all the other one-day surges and subsequent pullbacks we've seen from the stock since February of this year. Today's pop from OXGN, however, is quite different than all the rest... this time, it's got a legitimate shot at following through on the upside effort. Ergo, this little biopharma name is actually one of the market's best 'trades' right now.